Osteonecrosis asociada al uso de bifosfonatos: A propósito de un caso clínico
Biphosphonates reduce the risk of skeletal events and are currently part of standards of therapy in myeloma. Recently, zoledronate and pamidronate have been linked to osteonecrosis of the jaw, specially after surgical dental procedures. We report a 84 year-old man with multiple myeloma who developed...
Guardado en:
Autores principales: | Anguita C,Timoleón, Agurto P,Jaime, Roa E,Iván, Laissle C,German |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2006
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000900011 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Osteonecrosis de los maxilares asociada a medicamentos: revisión de la literatura y propuesta para la prevención y manejo
por: Foncea,Camila, et al.
Publicado: (2020) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011) -
The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
por: Wang Z, et al.
Publicado: (2021) -
Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021) -
Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Paul K Piper Jr, et al.
Publicado: (2009)